A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia

NCT02988973 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: roxadustat
DRUG: DA

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]